# [Retracted] Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway

**Authors:** Zhi Teng, Shijuan Xu, Qin Lei

PMC · DOI: 10.3892/or.2024.8725 · Oncology Reports · 2024-03-11

## Full-text entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}
- **Diseases:** acute leukemia (MESH:D015470), tumor (MESH:D009369)
- **Chemicals:** Tanshinone IIA (MESH:C021751), imatinib (MESH:D000068877)
- **Cell lines:** TIB-152 — Homo sapiens (Human), Huntington's disease, Induced pluripotent stem cell (CVCL_WR61)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10955357/full.md

---
Source: https://tomesphere.com/paper/PMC10955357